Vanguard Personalized Indexing Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Buy |
216,910
+37,578
| +21% | +$4.04M | 0.26% | 56 |
|
|
2025
Q1 | $18.1M | Buy |
179,332
+14,554
| +9% | +$1.47M | 0.27% | 60 |
|
|
2024
Q4 | $14.7M | Buy |
164,778
+9,057
| +6% | +$809K | 0.22% | 68 |
|
|
2024
Q3 | $13M | Buy |
155,721
+10,897
| +8% | +$913K | 0.21% | 73 |
|
|
2024
Q2 | $11.1M | Buy |
144,824
+20,142
| +16% | +$1.55M | 0.21% | 74 |
|
|
2024
Q1 | $8.54M | Buy |
124,682
+8,903
| +8% | +$610K | 0.18% | 91 |
|
|
2023
Q4 | $6.69M | Buy |
115,779
+14,497
| +14% | +$838K | 0.17% | 99 |
|
|
2023
Q3 | $5.35M | Buy |
101,282
+2,333
| +2% | +$123K | 0.16% | 105 |
|
|
2023
Q2 | $5.35M | Buy |
98,949
+5,205
| +6% | +$282K | 0.16% | 102 |
|
|
2023
Q1 | $4.69M | Buy |
93,744
+4,439
| +5% | +$222K | 0.16% | 111 |
|
|
2022
Q4 | $4.13M | Buy |
89,305
+10,928
| +14% | +$506K | 0.17% | 109 |
|
|
2022
Q3 | $3.04M | Buy |
78,377
+8,031
| +11% | +$311K | 0.14% | 140 |
|
|
2022
Q2 | $2.62M | Buy |
70,346
+11,450
| +19% | +$427K | 0.12% | 158 |
|
|
2022
Q1 | $2.61M | Buy |
58,896
+20,604
| +54% | +$913K | 0.13% | 145 |
|
|
2021
Q4 | $1.63M | Buy |
38,292
+1,251
| +3% | +$53.2K | 0.1% | 218 |
|
|
2021
Q3 | $1.61M | Buy |
37,041
+4,697
| +15% | +$204K | 0.14% | 138 |
|
|
2021
Q2 | $1.38M | Buy |
32,344
+13,657
| +73% | +$584K | 0.14% | 145 |
|
|
2021
Q1 | $722K | Buy |
18,687
+5,181
| +38% | +$200K | 0.11% | 217 |
|
|
2020
Q4 | $486K | Buy |
13,506
+1,003
| +8% | +$36.1K | 0.11% | 226 |
|
|
2020
Q3 | $478K | Buy |
12,503
+5,464
| +78% | +$209K | 0.13% | 184 |
|
|
2020
Q2 | $247K | Buy |
+7,039
| New | +$247K | 0.11% | 245 |
|